results from the phase iii echo trial of acalabrutinib plus br in mcl
Published 2 months ago • 278 plays • Length 2:49Download video MP4
Download video MP3
Similar videos
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:39
phase i/ii trial of adct-602 in b-all
-
2:43
the management of advanced phase mpns
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:46
phase ii trial in progress: astx727 ± venetoclax in newly diagnosed mds/mpn
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
0:50
insights into the phase ii window-2 trial
-
1:43
first results of the apollo trial: atra-ato versus soc in high-risk acute promyelocytic leukemia
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
4:53
revisiting clinical trial design – more adaptability in phase i – iii?
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
4:03
a phase i/ii study evaluating quizartinib plus decitabine and venetoclax in flt3-mutated aml
-
2:46
a phase ii trial of pembrolizumab for richter's transformation of cll